An Observational Study to Evaluate the Efficacy and Safety of K-CAB Tab./K-CAB ODT(Tegoprazan) in GERD Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19+
SponsorHK inno.N Corporation
About this trial
This study aims to evaluate the status of AE and improvement effect of K-CAB Tab/K-CAB ODT(Tegoprazan) 50mg in patients with GERD.
Eligibility criteria
Qualifiers
Subjects over 19 years of age as of the date of consent
Subjects with a total score of 8 or more in the Korean Gastroesophageal Reflux Disease Questionnaire (GerdQ) based on Visit 1
Subjects who voluntarily decides to participate and agrees in writing to the consent form of the study
Disqualifiers
Subjects who have hypersensitivity reactions and a medical history of Benzimidazole or components of the investigational drug
Subjects on Atazanavir, Nelfinavir, or Rilpivirine-containing medications
Pregnant and lactating women
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov